Table 2 Correlation of gene variants with neonatal hyperbilirubinemia by univariate analysis
From: Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan
Gene variant | Hyperbilirubinemia | p value | |
|---|---|---|---|
Yes | No | ||
N = 100 | N = 344 | ||
ABO incompatibility | 17 (17.0 %) | 55 (16.0 %) | 0.809 |
G6PD deficiency | 6 (6.0 %) | 8 (2.3 %) | 0.096 |
Alpha thalassemia | 4 (4.0 %) | 18 (5.2 %) | 0.796 |
UGT1A1 (nt211) | 0.015 | ||
GA | 39 (39.0 %) | 91 (26.5 %) | |
GG | 61 (61.0 %) | 253 (73.5 %) | |
SLCO1B1 (nt388) | 0.449 | ||
GA | 28 (28.0 %) | 110 (32.0 %) | |
GG | 72 (72.0 %) | 234 (68.0 %) | |
HO-1 promoter (GT)n allele | |||
< 24 repeats (short) | 59 (59.0 %) | 116 (33.7 %) | <0.001 |
≥ 24 repeats (long) | 41 (41.0 %) | 228 (66.3 %) | |